Biotech stocks may offer your portfolio an element of growth, and that's because these companies are sharply focused on ...

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering ...

Investors are increasingly wary of the rare-disease space, spooked by a regulatory shift.

With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter, ...

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

Venture capital firm Portal Innovations is planning to open a 30,000-square-foot science incubator in Salt Lake City while ...

When GSK’s new CEO Luke Miels told investors last month that “smart business development” is a key pillar for his strategy, he wasn’t lying. | Like Merck & Co.’s PAH drug Winrevair—which brought in $1 ...

Tomorrow BioTech and Green2Gold unite to support biotech and green innovators with labs, mentorship, and a path to ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

This biotech powerhouse could maintain its strength for the long term.

February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...

Biotech has faced slim funding for years now. As money starts to flow back into the space, it's good news for laboratory real ...